Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-31No description of principal activityfalse2024-04-011true3trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 04371608 2024-04-01 2025-03-31 04371608 2023-04-01 2024-03-31 04371608 2025-03-31 04371608 2024-03-31 04371608 1 2024-04-01 2025-03-31 04371608 d:Director3 2024-04-01 2025-03-31 04371608 c:CurrentFinancialInstruments 2025-03-31 04371608 c:CurrentFinancialInstruments 2024-03-31 04371608 c:CurrentFinancialInstruments c:WithinOneYear 2025-03-31 04371608 c:CurrentFinancialInstruments c:WithinOneYear 2024-03-31 04371608 c:ShareCapital 2025-03-31 04371608 c:ShareCapital 2024-03-31 04371608 c:SharePremium 2025-03-31 04371608 c:SharePremium 2024-03-31 04371608 c:CapitalRedemptionReserve 2025-03-31 04371608 c:CapitalRedemptionReserve 2024-03-31 04371608 c:RetainedEarningsAccumulatedLosses 2025-03-31 04371608 c:RetainedEarningsAccumulatedLosses 2024-03-31 04371608 d:OrdinaryShareClass2 2024-04-01 2025-03-31 04371608 d:OrdinaryShareClass2 2025-03-31 04371608 d:OrdinaryShareClass2 2024-03-31 04371608 d:OrdinaryShareClass3 2024-04-01 2025-03-31 04371608 d:OrdinaryShareClass3 2025-03-31 04371608 d:OrdinaryShareClass4 2024-04-01 2025-03-31 04371608 d:OrdinaryShareClass4 2025-03-31 04371608 d:OrdinaryShareClass4 2024-03-31 04371608 d:OrdinaryShareClass5 2024-04-01 2025-03-31 04371608 d:OrdinaryShareClass5 2025-03-31 04371608 d:OrdinaryShareClass5 2024-03-31 04371608 d:FRS102 2024-04-01 2025-03-31 04371608 d:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 04371608 d:FullAccounts 2024-04-01 2025-03-31 04371608 d:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 04371608 6 2024-04-01 2025-03-31 04371608 e:PoundSterling 2024-04-01 2025-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 04371608









LONDON HYPERBARIC MEDICINE (LHM) HEALTHCARE LIMITED







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

 
LONDON HYPERBARIC MEDICINE (LHM) HEALTHCARE LIMITED
REGISTERED NUMBER: 04371608

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Investments
 4 
392,742
392,742

  

Creditors: amounts falling due within one year
 5 
(380,185)
(380,185)

Net current liabilities
  
 
 
(380,185)
 
 
(380,185)

  

Net assets
  
12,557
12,557


Capital and reserves
  

Called up share capital 
 6 
72
125

Share premium account
  
6,236
6,236

Capital redemption reserve
  
1,040
987

Profit and loss account
  
5,209
5,209

  
12,557
12,557


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 23 December 2025.




K Adams
Director

The notes on pages 2 to 4 form part of these financial statements.

Page 1

 
LONDON HYPERBARIC MEDICINE (LHM) HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

London Hyperbaric Medicine (LHM) Healthcare Limited ("the Company") is a private company limited by shares and incorporated in England & Wales. Its registered office is Whipps Cross Hospital Hyperbaric Unit, Whipps Cross Road, London, E11 1RG.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The company is the parent undertaking of a small group and as such is not required by the Companies Act 2006 to prepare group accounts. These financial statements therefore present information about the company as an individual undertaking and not about its group.

The following principal accounting policies have been applied:

 
2.2

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.3

Creditors

Short term creditors are measured at the transaction price.

 
2.4

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2024 - 3).

Page 2

 
LONDON HYPERBARIC MEDICINE (LHM) HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

4.


Fixed asset investments





Investments in subsidiary companies

£



Cost 


At 1 April 2024
392,742



At 31 March 2025

392,742






Net book value



At 31 March 2025
392,742



At 31 March 2024
392,742


5.


Creditors: Amounts falling due within one year

2025
2024
£
£

Amounts owed to group undertakings
380,185
380,185



6.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



221 (2024 - 118 Ordinary A shares of £1 each) Ordinary A shares of £0.01 each
2
118
6,300 (2024 - Nil) Non Voting shares of £0.01 each
63
-
400 (2024 - 4 Ordinary C shares of £1 each) Ordinary C shares of £0.01 each
4
4
300 (2024 - 3 Ordinary D shares of £1 each) Ordinary D shares of £0.01 each
3
3

72

125

During the year the Company's Ordinary £1 shares were sub-divided into Ordinary £0.01 shares. 11,579 Ordinary A shares were authorised to be purchased by the Company for total consideration of £4,310,806. On 31 May 2024, 5,279 shares were bought by the company for £1,965,350 and subsequently cancelled.


Page 3

 
LONDON HYPERBARIC MEDICINE (LHM) HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

7.


Post balance sheet events

Post year end on 31 May 2025, 2,100 Non - Voting £0.01 shares were bought by the company for £781,820 and subsequently cancelled.

 
Page 4